1 – 20 of 43
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Prevalence and functional impact of parkinsonian signs in older adults from the Good Aging in Skåne study : Parkinsonian signs in older adults
(
- Contribution to journal › Article
- 2021
-
Mark
How to detect late-onset inborn errors of metabolism in patients with movement disorders - A modern diagnostic approach
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
(
- Contribution to journal › Letter
- 2016
-
Mark
Autosomal dominant Parkinson's disease caused by SNCA duplications.
(
- Contribution to journal › Article
-
Mark
Wilson disease: Acute dystonia during treatment with SSRI or SNRI
2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.140-141(
- Contribution to journal › Published meeting abstract
-
Mark
Tobacco increases dystonia risk but may ameliorate symptoms
2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.137-138(
- Contribution to journal › Published meeting abstract
-
Mark
Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials
(
- Contribution to journal › Letter
-
Mark
Cognitive decline and quality of life in incident Parkinson's disease : The role of attention
(
- Contribution to journal › Article
- 2015
-
Mark
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations
(
- Contribution to journal › Scientific review
-
Mark
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.
(
- Contribution to journal › Scientific review
-
Mark
The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system.
(
- Contribution to journal › Article
-
Mark
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.
(
- Contribution to journal › Article
- 2014
-
Mark
Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.
(
- Contribution to journal › Article
-
Mark
Women pioneers in basal ganglia surgery
(
- Contribution to journal › Scientific review
-
Mark
Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: An international multicenter study.
(
- Contribution to journal › Article
-
Mark
Autosomal dominant cerebellar ataxia with slow ocular saccades, neuropathy and orthostatism: A novel entity?
(
- Contribution to journal › Article
-
Mark
Atypical Friedreich ataxia in patients with FXN p.R165P point mutation or comorbid hemochromatosis.
(
- Contribution to journal › Article
-
Mark
Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
(
- Contribution to journal › Article
-
Mark
Predictors of Parkinson's disease dementia : towards targeted therapies for a heterogeneous disease
(
- Contribution to journal › Article